Recurring concern

Failure to reliably investigate metabolic causes of acute clinical presentations

Pin Get email alerts Request correction

First reported 9 Aug 2023•Latest report 4 Mar 2026

Definition

What this concern includes

Includes failures to recognise, investigate or escalate possible metabolic causes of acute or unexplained presentations, including incomplete exploration of metabolic acidosis causes and unclear guidance on when metabolic screening or ammonia testing is indicated.

Not included

  • Excludes general diagnostic delays or incomplete clinical investigations where a metabolic cause is not materially involved.
  • Excludes treatment failures after an appropriate metabolic cause has been investigated and identified.
  • Excludes condition-specific metabolic pathways when the assertion is confined to a more specific established concern.
  • Excludes generic training, communication or documentation deficiencies unless they directly impair investigation of metabolic causes.
Reports
3

Distinct published reports

Individual concerns
5

A report can raise multiple concerns

Date range
2023–2026

First to latest report issue date

Stated actions
2

Described in published responses

Reports over time

Reports over time

Reports about this concern issued each year.

* 2026 is projected from reports observed to 7 Sep 2026.

Most frequent recipients

Most frequent recipients

Reports about this concern sent to each recipient.

Faculty of Intensive Care Medicine1
Food Standards Agency1
Mid and South Essex NHS Foundation Trust1
NHS England1
Royal College of Emergency Medicine1
Royal College of Midwives1
Royal College of Obstetricians and Gynaecologists1
Royal College of Paediatrics and Child Health1
Royal College of Physicians1

Concerns and responses across reports

Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.

  1. Essex

    AI-generated summary

    Viviana-Ray Winnie Elsie Wendy Butnaru · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Viviana-Ray Winnie Elsie Wendy Butnaru attended the Children’s Emergency Department on 24 October 2024 and died at Basildon Hospital on 25 October 2024 after cardiac arrest. The stated cause of death was myocarditis caused by Parvovirus, contributed to by bronchiolitis and bronchopneumonia. Concerns included delayed reporting of chest X-rays showing cardiomegaly, incomplete exploration of metabolic acidosis, failures in escalation and review processes, and incomplete documentation and handovers.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to fully explore underlying causes of metabolic acidosis

    Wider context from the report

    “(4) Underlying causes for metabolic acidosis were not fully explored. Greater awareness of the difference between metabolic and respiratory acidosis is required. ”

    Source location

    Viviana-Ray Winnie Elsie Wendy Butnaru · Prevention of Future Deaths report
    Page 3 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Disseminate learning about metabolic acidosis and associated safety actions through multidisciplinary forums, teaching, simulation and a staff safety bulletin.

    Verbatim wording from the response

    “Viviana-Ray’s case has been discussed at various trust forums, to share learning and the associated actions that have been taken. The case was presented at Basildon’s site Mortality and Morbidity (M&M) meeting in March 2026, which is attended by consultants, tier 1 and 2 doctors and clinical nurse facilitators. Her case has also been discussed at the cross-site Grand Round in January 2026, during this meeting the case was discussed with learnings and differential for metabolic acidosis including cardiac and attended by consultants, tier 1 and 2 doctors and Associate Directors of Nursing. A safety bulletin has also been circulated to all staff in February 2026.”

    Source location

    Response from Mid and South Essex NHS Foundation Trust
    Page 2 · response
    Published 9 March 2026

    Open published response
  2. Birmingham and Solihull

    AI-generated summary

    Chloe Angela Ulett · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Chloe Angela Ulett died at Birmingham Heartlands Hospital on 28 September 2024 from a previously undiagnosed urea cycle disorder that had been unmasked by giving birth. She developed confusion and excessive drowsiness after childbirth, was initially diagnosed with iron deficiency and discharged, and ammonia testing was delayed until several days later. The principal concerns were that early ammonia testing was not routine, relevant guidance was unclear and not embedded in adult medicine, and there remained a national risk of delayed diagnosis.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure of RCEM investigation guidance to identify when metabolic screens and ammonia levels are clinically indicated

    Wider context from the report

    “4. The Royal College of Emergency Medicine (RCEM) guideline ‘Acute Behavioural Disturbance in Adult Emergency Departments’ (Oct 2023) was the most appropriate guideline at the time, it advises doing tests as clinically indicated including appropriate metabolic screen to include blood tests to check ammonia levels. 5. The RCEM guidance was not, however, considered by any of the practitioners in this case (the deceased was treated in the emergency department, by the acute medical team and then in intensive care with several other specialities consulting before ammonia testing was recommended by neurology). 6. The evidence was that this RCEM guidance is not yet embedded in adult medicine in the emergency department. 7. Further, evidence was given that the content and phrasing of the RCEM guidance was not helpful in the context of a case of acute behavioural disorder resulting from a urea cycle disorder because urea cycle disorders or metabolic disorders (‘ABD’) are not contained in the table of potential factors leading to ABD presentation in section 1, and in section 4 the recommended investigations do not assist in identifying when metabolic screens, and specifically ammonia levels, are clinically indicated. Nor is it clear why ammonia levels are placed in brackets. Additionally, there is no guidance as to the appropriate referral pathway to be followed when ammonia levels are raised. The RCEM guidance was updated in May 2025 but these matters have not changed from the 2023 version. 8. It was acknowledged that the presentation of adults with undiagnosed Urea Cycle Disorders is very rare and ammonia levels will not normally be clinically indicated for patients with ABD. However, it is the rarity of these presentations and the likely inexperience of those outside inherited metabolic diseases teams that gives rise to the need for clear guidance. ”

    Source location

    Chloe Angela Ulett · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Omission of urea cycle and metabolic disorders from RCEM behavioural disturbance risk factors

    Wider context from the report

    “4. The Royal College of Emergency Medicine (RCEM) guideline ‘Acute Behavioural Disturbance in Adult Emergency Departments’ (Oct 2023) was the most appropriate guideline at the time, it advises doing tests as clinically indicated including appropriate metabolic screen to include blood tests to check ammonia levels. 5. The RCEM guidance was not, however, considered by any of the practitioners in this case (the deceased was treated in the emergency department, by the acute medical team and then in intensive care with several other specialities consulting before ammonia testing was recommended by neurology). 6. The evidence was that this RCEM guidance is not yet embedded in adult medicine in the emergency department. 7. Further, evidence was given that the content and phrasing of the RCEM guidance was not helpful in the context of a case of acute behavioural disorder resulting from a urea cycle disorder because urea cycle disorders or metabolic disorders (‘ABD’) are not contained in the table of potential factors leading to ABD presentation in section 1, and in section 4 the recommended investigations do not assist in identifying when metabolic screens, and specifically ammonia levels, are clinically indicated. Nor is it clear why ammonia levels are placed in brackets. Additionally, there is no guidance as to the appropriate referral pathway to be followed when ammonia levels are raised. The RCEM guidance was updated in May 2025 but these matters have not changed from the 2023 version. 8. It was acknowledged that the presentation of adults with undiagnosed Urea Cycle Disorders is very rare and ammonia levels will not normally be clinically indicated for patients with ABD. However, it is the rarity of these presentations and the likely inexperience of those outside inherited metabolic diseases teams that gives rise to the need for clear guidance. ”

    Source location

    Chloe Angela Ulett · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Lack of best-practice guidance recommending ammonia testing for undifferentiated acutely confused patients

    Wider context from the report

    “2. There are no identified NICE or BMJ best practice guidelines which currently recommend testing of ammonia levels for undifferentiated acutely presenting confused patients. 3. Nationally, early measurement of ammonia levels in adults presenting to the emergency department and other units for investigation and management of behavioural change and confusion are not routine practice. ”

    Source location

    Chloe Angela Ulett · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Development of guidance on this area is best dealt with by specialist societies such as RCEM or BIMDG.

    Verbatim wording from the response

    “We believe that this is an area best dealt with by specialist societies, such as the RCEM or the British Inherited Metabolic Diseases Group (BIMDG). We note that you have already written to RCEM regarding their guidance and indicated that during the course of your inquest, evidence indicated that this guidance is not embedded in adult medicine at University Hospitals of Birmingham NHS Foundation Trust. NICE does not have anything to add to the recommendations provided by the RCEM guideline.”

    Source location

    2026-0086 - Response from NICE
    Page 1 · response
    Published 13 February 2026

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    No additional recommendations are considered necessary because the existing RCEM guideline already addresses the relevant concerns.

    Verbatim wording from the response

    “We believe that this is an area best dealt with by specialist societies, such as the RCEM or the British Inherited Metabolic Diseases Group (BIMDG). We note that you have already written to RCEM regarding their guidance and indicated that during the course of your inquest, evidence indicated that this guidance is not embedded in adult medicine at University Hospitals of Birmingham NHS Foundation Trust. NICE does not have anything to add to the recommendations provided by the RCEM guideline.”

    Source location

    2026-0086 - Response from NICE
    Page 1 · response
    Published 13 February 2026

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Matters in points 3–11 are outside the respondent’s role, so it will not comment further on them.

    Verbatim wording from the response

    “Points 3-11 do not relate to the role of the RCM and therefore we feel unable to comment further.”

    Source location

    2026-0086 - Response from Royal College of Midwives
    Page 2 · response
    Published 13 February 2026

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Routine ammonia testing is not warranted in all confused patients because hyperammonaemia is a diagnosis of exclusion and sepsis requires priority assessment.

    Verbatim wording from the response

    “Hyperammonaemia is rare but the presentation of those with confusion due to any cause is high in the acute setting. 10-20% of all admissions present with confusion due to a wide variety of issues (National Institute for Health and Care Excellence: Delirium, prevention, diagnosis and management (CG103). London: NICE; 2010 (updated 2019)). Hyperammonaemia remains a diagnosis of exclusion and as such, ammonia levels are not usually in the first bloods sent for a patient, as the primary aim in someone presenting with confusion is to ensure they do not have sepsis. As highlighted by this challenging case, hyperammonaemia remains a diagnosis that should be carefully considered when the cause of acute confusion is unclear.”

    Source location

    2026-0086- Response from Royal College of Physicians
    Page 2 · response
    Published 13 February 2026

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Without specific ammonia-testing recommendations, midwives follow national guidance and local policies and do not routinely initiate testing without medical discussion.

    Verbatim wording from the response

    “2. There are no identified NICE or BMJ best practice guidelines which currently recommend testing of ammonia levels for undifferentiated acutely presenting confused patients.”

    Source location

    2026-0086 - Response from Royal College of Midwives
    Page 2 · response
    Published 13 February 2026

    Open published response
  3. Milton Keynes

    AI-generated summary

    Rohan GODHANIA · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Rohan GODHANIA became unwell after consuming a high-protein drink on 15 August 2020, was admitted to hospital, and died on 18 August 2020 from Ornithine Transcarbamylase Deficiency. The report identifies concerns about inconsistent NHS classification of teenagers aged 16–18 and a lack of emergency-department guidance on ammonia testing for patients presenting in extremis with an unknown cause.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Lack of guidance for testing ammonia levels in patients presenting in extremis with an unknown cause

    Wider context from the report

    “2. Guidance for Testing for Ammonia in Emergency Departments The other concerning issue that requires immediate attention is the lack of guidance for testing ammonia levels in patients who present in extremis with an unknown cause. Timely and accurate diagnosis is essential in such cases to ensure appropriate treatment and prevent unnecessary deaths. The guideline should include clear protocols for conducting ammonia tests, interpreting the results and making informed clinical decisions based on the findings. The guidance should be disseminated to all emergency departments and healthcare facilities. ”

    Source location

    Rohan GODHANIA · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Issue a Patient Safety Bulletin highlighting prompt ammonia measurement and action when hyperammonaemia is identified.

    Verbatim wording from the response

    “NHS England’s National Patient Safety Team have also undertaken work with the Royal College of Pathologists (RCPath) on the specific issue of hyperammonaemia and ammonia testing. As a result of this a Patient Safety Bulletin was issued. This highlighted the need for ‘prompt measurement of ammonia and action in the event of hyperammonaemia’.”

    Source location

    Response from NHS England
    Page 2 · response
    Published 6 September 2023

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    NHS England is not the lead organisation for developing guidance on ammonia testing in emergency departments.

    Verbatim wording from the response

    “NHS England would not be the lead organisation for the relevant clinical guidance, and you may wish to refer your concerns to the Royal Colleges. NHS England has, however, engaged with the Royal College of Emergency Medicine (RCEM) on this case, and they have advised that they will be making an amendment to their existing Acute Behavioural Disturbance guidelines to specifically mention ammonia levels, should a clinician be considering the need for a metabolic screen.”

    Source location

    Response from NHS England
    Page 2 · response
    Published 6 September 2023

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Concerns about ammonia-testing guidance should be referred to the Royal Colleges.

    Verbatim wording from the response

    “NHS England would not be the lead organisation for the relevant clinical guidance, and you may wish to refer your concerns to the Royal Colleges. NHS England has, however, engaged with the Royal College of Emergency Medicine (RCEM) on this case, and they have advised that they will be making an amendment to their existing Acute Behavioural Disturbance guidelines to specifically mention ammonia levels, should a clinician be considering the need for a metabolic screen.”

    Source location

    Response from NHS England
    Page 2 · response
    Published 6 September 2023

    Open published response
Back to top

Data last updated 7 September 2026